HOXA9 and leukemia: JMJD1C regulates aberrant metabolic processes in acute myeloid leukemia, contributes to MLL-AF9/HOXA9-mediated self-renewal of leukemia stem cells, and suppresses leukemia cell growth by catalyzing H3K9 demethylation [134,135,136].